Cytokinetics CYTK
NASDAQ CYTK
$65.62 -0.29 (-0.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Gross Profit (2025 - 2026)

Updated

Cytokinetics (CYTK) recorded Gross Profit of $25.89 million in Q2 2026, down 61.2% from $66.77 million a year earlier but up 34.9% from the prior quarter.

Analysis

Cytokinetics (CYTK) Gross Profit (2025 - 2026) Analysis & Trends

On a TTM basis, Cytokinetics' Gross Profit came in at $113.44 million as of Jun 30, 2026.

  • Quarterly Gross Profit has ranged from $1.58 million in Q1 2025 to $66.77 million in Q2 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cytokinetics 9.16 Bn 5.33 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.89 Mn
Mar 31, 2026 19.20 Mn
Jun 30, 2025 66.77 Mn
Mar 31, 2025 1.58 Mn
API Access

Cytokinetics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CYTK&period=max&api_key=YOUR_API_KEY